[{"id":"58c1e0c0-b674-448a-ae94-6a539accdd99","acronym":"","url":"https://clinicaltrials.gov/study/NCT05198830","created_at":"2022-01-20T15:53:52.796Z","updated_at":"2024-07-02T16:34:26.376Z","phase":"Phase 2","brief_title":"Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT05198830","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • carboplatin • Imfinzi (durvalumab) • pemetrexed • Pemfexy (pemetrexed) • methoxyamine (TRC102)"],"overall_status":"Recruiting","enrollment":" Enrollment 42","initiation":"Initiation: 12/15/2022","start_date":" 12/15/2022","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2024-06-13"},{"id":"a432a555-c2f8-43ba-befa-5a91db04db5c","acronym":"","url":"https://clinicaltrials.gov/study/NCT02535325","created_at":"2021-01-18T12:15:42.112Z","updated_at":"2025-02-25T16:30:42.064Z","phase":"Phase 1","brief_title":"Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer","source_id_and_acronym":"NCT02535325","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" ERCC1 • NKX2-1","pipe":"","alterations":" ","tags":["ERCC1 • NKX2-1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • pemetrexed • Pemfexy (pemetrexed) • methoxyamine (TRC102)"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 09/30/2015","start_date":" 09/30/2015","primary_txt":" Primary completion: 02/27/2020","primary_completion_date":" 02/27/2020","study_txt":" Completion: 06/14/2022","study_completion_date":" 06/14/2022","last_update_posted":"2022-06-30"}]